Total Payments
$136,239
2024 Payments
$15,383
Companies
4
Transactions
48
Medicare Patients
3,355
Medicare Billing
$182,756
Payment Breakdown by Category
Consulting$67,338 (49.4%)
Other$57,100 (41.9%)
Travel$10,994 (8.1%)
Food & Beverage$806.88 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $67,338 | 14 | 49.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,100 | 4 | 41.9% |
| Travel and Lodging | $10,994 | 9 | 8.1% |
| Food and Beverage | $806.88 | 17 | 0.6% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$136,239
44 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharma AG | $71,895 | 20 | $0 (2023) |
| Spark Therapeutics, Inc. | $58,943 | 23 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $5,400 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,383 | 10 | Spark Therapeutics, Inc. ($15,383) |
| 2023 | $30,943 | 5 | Novartis Pharma AG ($16,913) |
| 2022 | $42,840 | 14 | Spark Therapeutics, Inc. ($29,258) |
| 2021 | $5,400 | 2 | Regeneron Pharmaceuticals, Inc. ($5,400) |
| 2020 | $41,402 | 13 | Novartis Pharma AG ($41,402) |
| 2019 | $114.83 | 2 | Spark Therapeutics, Inc. ($114.83) |
| 2018 | $157.58 | 2 | Spark Therapeutics, Inc. ($157.58) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: OCULAR | ||||||
| 07/15/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Travel and Lodging | Cash or cash equivalent | $149.88 | General |
| Category: OCULAR | ||||||
| 07/15/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Travel and Lodging | Cash or cash equivalent | $129.27 | General |
| Category: OCULAR | ||||||
| 07/15/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | Cash or cash equivalent | $71.62 | General |
| Category: OCULAR | ||||||
| 07/01/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,030.00 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Travel and Lodging | In-kind items and services | $667.19 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Travel and Lodging | In-kind items and services | $187.28 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $42.51 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: OCULAR | ||||||
| 2024 | Digital Diagnostics Inc. | — | — | — | $0.00 | Ownership |
| 11/21/2023 | Novartis Pharma AG | LUXTURNA (Drug) | Consulting Fee | Cash or cash equivalent | $6,150.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/15/2023 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,030.00 | General |
| Category: OCULAR | ||||||
| 03/21/2023 | Novartis Pharma AG | LUXTURNA (Drug) | Consulting Fee | Cash or cash equivalent | $6,662.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/07/2023 | Novartis Pharma AG | LUXTURNA (Drug) | Consulting Fee | Cash or cash equivalent | $4,100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 2023 | Digital Diagnostics Inc. | — | — | — | $0.00 | Ownership |
| 10/18/2022 | Novartis Pharma AG | LUXTURNA (Drug) | Consulting Fee | Cash or cash equivalent | $3,075.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/06/2022 | Novartis Pharma AG | LUXTURNA (Drug) | Consulting Fee | Cash or cash equivalent | $3,075.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/07/2022 | Novartis Pharma AG | LUXTURNA (Drug) | Consulting Fee | Cash or cash equivalent | $3,331.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/15/2022 | Novartis Pharma AG | LUXTURNA (Drug) | Consulting Fee | Cash or cash equivalent | $4,100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/04/2022 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,520.00 | General |
| Category: OCULAR | ||||||
| 02/04/2022 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,520.00 | General |
| Category: OCULAR | ||||||
| 01/25/2022 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 01/25/2022 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.53 | General |
| 01/25/2022 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $6.94 | General |
| 01/24/2022 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $64.72 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 829 | 1,040 | $293,707 | $39,987 |
| 2022 | 8 | 710 | 1,030 | $282,316 | $40,881 |
| 2021 | 9 | 897 | 1,219 | $398,944 | $55,867 |
| 2020 | 9 | 919 | 1,301 | $327,441 | $46,021 |
Total Patients
3,355
Total Services
4,590
Medicare Billing
$182,756
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 114 | 154 | $58,806 | $10,297 | 17.5% |
| 92134 | Imaging of retina | Facility | 2023 | 243 | 347 | $60,047 | $5,699 | 9.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 43 | 56 | $30,464 | $4,246 | 13.9% |
| 67028 | Injection of drug into eye | Facility | 2023 | 38 | 54 | $29,125 | $3,877 | 13.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 35 | 35 | $20,491 | $3,156 | 15.4% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 103 | 107 | $28,530 | $3,123 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 35 | $13,545 | $2,536 | 18.7% |
| 92134 | Imaging of retina | Office | 2023 | 103 | 125 | $21,875 | $2,306 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 38 | 46 | $11,774 | $2,107 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $5,698 | $1,078 | 18.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 25 | 25 | $6,750 | $905.52 | 13.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Facility | 2023 | 21 | 23 | $2,168 | $333.20 | 15.4% |
| 76510 | 1d and 2d ultrasound scan of eye tissue and structures | Facility | 2023 | 11 | 11 | $4,434 | $322.85 | 7.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 138 | 214 | $80,694 | $14,929 | 18.5% |
| 92134 | Imaging of retina | Facility | 2022 | 265 | 448 | $75,067 | $7,513 | 10.0% |
| 67028 | Injection of drug into eye | Facility | 2022 | 60 | 95 | $47,222 | $6,473 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 49 | 49 | $28,469 | $4,590 | 16.1% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 100 | 111 | $28,073 | $3,730 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 56 | 70 | $17,747 | $2,795 | 15.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Facility | 2022 | 30 | 31 | $2,866 | $498.93 | 17.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Facility | 2022 | 12 | 12 | $2,178 | $352.19 | 16.2% |
| 67108 | Repair of detached retina and drainage of eye fluid between lens and retina, with removal of vitreous fluid | Facility | 2021 | 12 | 12 | $81,831 | $10,420 | 12.7% |
| 67028 | Injection of drug into eye | Office | 2021 | 62 | 118 | $57,120 | $8,229 | 14.4% |
| 92134 | Diagnostic imaging of retina | Facility | 2021 | 280 | 413 | $66,869 | $7,364 | 11.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 86 | 109 | $40,532 | $7,244 | 17.9% |
About Dr. Stephen Russell, MD
Dr. Stephen Russell, MD is a Ophthalmology healthcare provider based in Iowa City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235130584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Russell, MD has received a total of $136,239 in payments from pharmaceutical and medical device companies, with $15,383 received in 2024. These payments were reported across 48 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($67,338).
As a Medicare-enrolled provider, Russell has provided services to 3,355 Medicare beneficiaries, totaling 4,590 services with total Medicare billing of $182,756. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Iowa City, IA
- Active Since 08/09/2005
- Last Updated 12/17/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1235130584
Products in Payments
- LUXTURNA (Drug) $71,895
- LUXTURNA (Biological) $58,725
- EYLEA (Biological) $5,400
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Iowa City
Keith Carter, Md, MD
Ophthalmology — Payments: $61,512
Ophthalmology $61,512
Alina Dumitrescu, Md, MD
Ophthalmology — Payments: $51,171
Ophthalmology $51,171
Dr. Erin Shriver, Md, MD
Ophthalmology — Payments: $34,811
Ophthalmology $34,811
Dr. James Folk, Md, MD
Ophthalmology — Payments: $12,963
Ophthalmology $12,963
Elliott Sohn
Ophthalmology — Payments: $7,094
Ophthalmology $7,094
Dr. Christopher Sales, M.d., M.p.h, M.D., M.P.H
Ophthalmology — Payments: $4,921
Ophthalmology $4,921